NEW YORK — Henry Schein said on Thursday that it has signed an agreement to distribute SD Biosensor's point-of-care immunochromatography test for SARS-CoV-2 in the US.
According to Henry Schein, the Standard Q COVID-19 IgM/IgG Rapid Test is designed for the qualitative presumptive detection of specific IgM and IgG antibodies to SARS-CoV-2 in a fingerstick blood sample. Results are available within 15 minutes with no instrumentation required.